Helping melanoma patients decide whether to choose adjuvant high-dose interferon-alpha2b

Karen E Hurley1, Paul B Chapman

  • 1Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

The Oncologist
|October 27, 2005
PubMed

Related Concept Videos